Commercial Litigation

Whether you are using the courts to achieve your business goals, or defending a significant damage claim, our team has the experience you need. We successfully defend, as well as litigate or mediate claims.

We provide you with smart and clear advice from seasoned litigators to resolve your disputes. When we accept an engagement, it is because we have the industry knowledge and cross-border litigation skills to solve your litigation matter with the least cost and distraction to you. We are trial lawyers and problem solvers.

With more than 800 litigation lawyers in over 45 offices worldwide in a practice whose roots run deep in a century of achievement, Hogan Lovells can steer you through the legal maze.

From risk analysis to crisis management, and from representation in a single court to advice in a multijurisdictional cross-border dispute, Hogan Lovells has the answers every step of the way.

Client results that speak for themselves

Lorem ipsum dolor sit amet consectetur arcu non eget.

120

Revenue Generation

Lorem ipsum dolor sit amet consectetur arcu non eget.

International arbitration

Investigations, White Collar, and Fraud

Employment

Technology Litigation

Commercial Litigation

Whether you are using the courts to achieve your business goals, or defending a significant damage claim, our team has the experience you need. We successfully defend, as well as litigate or mediate claims.

Find out more

We are trial lawyers and problem solvers.

Find out more

We are trial lawyers and problem solvers.

Find out more

We are trial lawyers and problem solvers.

Find out more

Our representative experience

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Acting for Libyan State institutions to establish constitutional basis for control of assets, including releasing monies subject to sanctions.

Acting for a US-based life sciences innovator to secure patient access to a life-saving treatment for an ultra-rare disease.

Acting for oil drilling companies in a judicial review challenge and CJEU proceedings against primary legislation imposing additional tax burden.

Acting in successful UK and European Court of Human Rights proceedings to recover monies owed by a Ukrainian State-owned entity.

Advising The Crown Estate on a range of constitutional issues, including the design and drafting of the legislative package to deliver Scottish devolution and related constitutional issues.

Advising Uber on an ongoing basis on its regulatory strategy to support the growth of its innovative service in regulated markets.

Advising a European life sciences business on a legal challenge against the European Commission before the CJEU.

Advising a drug manufacturer on navigating a Parliamentary inquiry and negotiations with the UK Government reaching an unprecedented agreement to provide life-changing treatment for cystic fibrosis.

Advising a number of businesses and government bodies on regulatory and policy responses to COVID-19.

Advising on Freedom of Information Act requests for details of communications with the UK Government in relation to Brexit.

Advising the Iceland Government on potential legal challenges to, and international engagement regarding, UK's response to the banking crisis.

Advising the UK Government on public law and legislative issues relating to the monetisation of the student loans portfolio.

Successfully defending ITV in a judicial review challenge regarding its broadcast coverage of the 2019 General Elections.

Twice successfully representing Uber in appeals against TfL, securing its ability to continue operating in London.

Other ways we can help you

Horizons at a glance

In our latest Horizons edition, we highlight standout chapters that offer a glimpse into the key insights and forward-looking perspectives shaping what’s next across the global sector landscape.

AI and Digital Health

What’s next for AI and Digital Health in life sciences and health care?

Discover the latest insights driving the future of AI and Digital Health in our 2025 Horizons edition.

Get a glimpse of what’s next:

AI in health care: What’s next?
Navigating digital health and SaMD regulation
Changes to reimbursement framework
Compliance

Explore more

APAC

In the APAC chapter of our 2025 Horizons edition, we highlight “China issues new rules on domestic responsible persons”, which covers the NMPA’s Interim Provisions issued on 13 November 2024 and set to take effect on 1 July 2025. These new rules strengthen regulatory oversight of overseas marketing authorization holders and their appointed domestic responsible persons, who will now share joint responsibility for fulfilling drug marketing authorization obligations and take on a much more prominent, consumer-facing role.

Explore more

Cross-jurisdictional

The cross-jurisdictional chapter features the complex regulatory landscape governing clinical trials involving genetically modified organisms (GMOs) in the EU. The piece explores how countries such as Belgium, Germany, Italy, the Netherlands, Spain, and France navigate a patchwork of evolving rules shaped by safety and environmental concerns.